Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions

By sjmartinez • August 8, 2024

Ljubimova JY, Holler E, Black KL, Ljubimov AV. Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (Lond). 2024 Aug 7:1-4. doi: 10.1080/17435889.2024.2380241. Epub ahead of print. PMID: 39109486.

Tags: Alzheimer's and tumor, BBB, blood brain barrier (BBB), Blood-brain-barrier, Cedars Sinai DoM, cell-specific drug delivery, central nervous system, CNS immunity, diabetic retinopathy, Endocrinology, multifunctional nanoparticles, normal, peptides, Publications

Molecular underpinnings of aging contributing to systemic sclerosis pathogenesis

Yang MM, Boin F, Wolters PJ. Molecular underpinnings of aging contributing to systemic sclerosis pathogenesis. Curr Opin Rheumatol. 2025 Jan 1;37(1):86-92. doi: 10.1097/BOR.0000000000001061. Epub 2024[...]

Polyploid cancer cells reveal signatures of chemotherapy resistance

Schmidt MJ, Naghdloo A, Prabakar RK, Kamal M, Cadaneanu R, Garraway IP, Lewis M, Aparicio A, Zurita-Saavedra A, Corn P, Kuhn P, Pienta KJ, Amend[...]

Implications of Tricuspid Regurgitation Severity in Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair

Shechter A, Taheri H, Nagasaka T, Gupta A, Kaewkes D, Patel V, Suruga K, Dhillon M, Koseki K, Koren O, Makar M, Skaf S, Patel[...]